Financhill
Back

Freeport-McMoRan Vs. Akero Therapeutics Industry Stock Comparison

Buy
67

FCX
Freeport-McMoRan

Last Price:
$43.28
Seasonality Move:
3.46%
Sell
40

AKRO
Akero Therapeutics

Last Price:
$49.21
Seasonality Move:
31.84%
Buy
67
Freeport-McMoRan (FCX) is a Buy

Is Freeport-McMoRan a Buy, Sell or Hold?

  • The current Freeport-McMoRan [FCX] share price is $43.28. The Score for FCX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • FCX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $49.23. The Score for AKRO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FCX Stock Price Chart

What is Freeport-McMoRan's stock price today?

  • The Freeport-McMoRan share price today is $43.28
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FCX is experiencing buying pressure, which is a positive indicator for future bullish movement.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $49.23
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing buying pressure, which is a positive indicator for future bullish movement.

FCX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.14 Buy
Relative Strength Index (14 RSI): 56.03 Buy
Chaikin Money Flow: 8842471 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (40.39 - 44.03) Buy
Bollinger Bands (100): (35.98 - 44) Buy

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.65 Sell
Relative Strength Index (14 RSI): 48.6 Sell
Chaikin Money Flow: 541980 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (47.97 - 50.87) Sell
Bollinger Bands (100): (41.22 - 53.36) Buy

FCX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.11 Buy
20-day SMA: 41.5 Buy
50-day SMA: 42.95 Buy
200-day SMA: 40.1 Buy
8-day EMA: 41.68 Buy
20-day EMA: 35.48 Buy
50-day EMA: 22.1 Buy
200-day EMA: 7.17 Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.68 Buy
20-day SMA: 48.97 Buy
50-day SMA: 51.4 Sell
200-day SMA: 42.35 Buy
8-day EMA: 48.71 Buy
20-day EMA: 49.29 Sell
50-day EMA: 49.64 Sell
200-day EMA: 43.29 Buy

Freeport-McMoRan Earnings Growth & FCX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.20 per share, an increase this year of $0.38 per share, and an increase next year of $0.85 per share.

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.13 per share, an increase this year of $0.23 per share, and a decrease next year of $0.61 per share.

Freeport-McMoRan Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):